Phase 2

Recruiting

NCT06873334

SKY-0515

View on ClinicalTrials.gov ↗

Timeline

Study Dates

Start Date

August 2025

Est. Completion

December 2029

Enrollment Target

100 participants

Status

Recruiting

Study Design

Primary Endpoint

Safety, tolerability, and change in huntingtin protein / RNA splicing biomarkers across dose cohorts

Registry

ClinicalTrials.gov Record

Registry ID

NCT06873334

Direct Link

clinicaltrials.gov/NCT06873334 ↗

Related Treatment

Treatment Being Studied